AkzoNobel and Axalta both announced today that they have halted discussions about a potential merger.
“The companies were unable to reach mutually agreeable terms,” Axalta says in a statement. The two coatings makers disclosed the existence of talks on 30 October, after reports appeared in the Wall Street Journal.
AkzoNobel is “focused on our strategic options to continue to develop our business and improve profitability in the future,” says CEO Thierry Vanlancker. Axalta “concluded we could not negotiate a transaction on terms that meet our criteria,” says chairman and CEO Charles Shaver. Those criteria include generating greater shareholder value than the company’s plans would as an independent entity, he adds.
The prospective merger was also seen as an attempt by AkzoNobel to fend off a renewed bid by PPG Industries, whose hostile bid for AkzoNobel was rebuffed in the spring. An AkzoNobel-Axalta transaction is “a plausible move, with attractive synergies and a good strategic fit, but the timing suggests the AkzoNobel board wants to block off any possibility of losing its independence,” Laurence Alexander, an analyst with Jefferies (New York), said when the rumors appeared.
Under Dutch law, PPG may launch a new bid for AkzoNobel in December. However, it is not clear that PPG intends to resume its pursuit of AkzoNobel. Statements from PPG executives, as well as analyst speculation, hint that a new bid is unlikely, at least for now. During PPG’s quarterly earnings call on 19 October, chairman and CEO Michael McGarry told investors that “we have moved on” from the merger proposal. “We are happy with our acquisition pipeline,” McGarry added.
“If PPG is posturing regarding lack of interest in re-engaging with Akzo, they are doing an excellent job of it,” says Kevin McCarthy, an analyst with Vertical Research Partners (Stamford, CT). “We detect near zero willingness to re-engage with Akzo at this juncture given the intransigence demonstrated by Akzo’s board.”
By Vincent Valk
Sourc: Chemical Week
Corteva (Indianapolis, Indiana) says it has signed a definitive agreement to acquire Stoller Group (Houston, Texas), a producer of biostimulants and plant nutrition products, for $1.2 billion. Stoller is one of the largest independent biologicals companies globally, with operations in more than 60 countries and more than $400 million in annual sales.
OMV has announced its new corporate structure today, designed to fully enable the delivery of Strategy 2030. The new organization will be built on five distinct areas. In addition to the CEO and CFO areas, three business segments will be established: Chemicals & Materials, Fuels & Feedstock, and Energy.
The European petchem sector is readying for some tough quarters. It’s a different picture in the US. So is this the best time ever to find a new role in the chemical industry? If you are in Europe, you would expect me to say probably not. But actually, it depends. So let me give you four answers to this question.